Case report: Short-course hypofractionated radiation therapy combined with immune checkpoint inhibitors for the treatment of advanced ovarian mucinous cystadenocarcinoma
BackgroundOvarian mucinous cystadenocarcinoma is a rare subtype of ovarian epithelial carcinoma that is resistant to platinum-based chemotherapy and has a poor prognosis, and there is no standard treatment plan for patients for whom multiline treatment has failed.Case presentationoma with FIGO stage...
Saved in:
Main Authors: | Xinan Wan, Mingxing Fang, Le Yuan, Hang Zhang, Dan Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1430474/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Investigation of the Predictive Factors of Recurrent Ovarian Mucinous Cystadenoma
by: Aykut Ozcan, et al.
Published: (2024-08-01) -
Case report: A rare case of a long-term survivor of glioblastoma who underwent two courses of hypofractionated radiotherapy as part of her care
by: Midhad Mrvoljak, et al.
Published: (2025-02-01) -
Combination of Cemiplimab and Radiotherapy in Advanced Squamous Cell Carcinoma
by: André Aparício Martins, et al.
Published: (2025-01-01) -
Tumor volume changes after stereotactic, hypofractionated and conventional radiotherapy in paragangliomas of head and neck
by: Paweł J. Polanowski, et al.
Published: (2024-09-01) -
Hypofractionated radiotherapy combined with a PD-1 inhibitor, granulocyte macrophage-colony stimulating factor, and thymosin-α1 in advanced metastatic solid tumors: a multicenter Phase II clinical trial
by: Jiamin Yu, et al.
Published: (2025-02-01)